Treatment Recommendations for New Anxiety
For patients with a new history of anxiety, first-line treatment should include selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), along with cognitive behavioral therapy (CBT). 1, 2
Pharmacological Treatment Options
First-Line Medications
- SSRIs are suggested as first-line pharmacotherapy for anxiety disorders due to their efficacy and favorable side effect profile 2, 3
- Specific SSRI options include:
- Venlafaxine (an SNRI) is an effective alternative when SSRIs are not tolerated or ineffective 2, 1
Medication Administration
- Start with a low dose and gradually increase to minimize side effects 4
- For SSRIs, therapeutic effects typically begin after 2-4 weeks of treatment 5
- Continue medication for at least 6-12 months after symptom remission to prevent relapse 6
- Common side effects of SSRIs/SNRIs include diarrhea, dizziness, dry mouth, fatigue, headache, nausea, sexual dysfunction, sweating, tremor, and weight gain 2
Psychological Interventions
Cognitive Behavioral Therapy (CBT)
- CBT is strongly recommended as a first-line treatment for anxiety disorders, either as standalone or adjunctive therapy 1, 2
- Individual CBT sessions are preferred over group therapy due to superior clinical and economic effectiveness 2
- CBT should be structured with approximately 14 sessions over 4 months, with each session lasting 60-90 minutes 2
- Key components of effective CBT include:
Alternative Psychological Approaches
- For patients who cannot or do not want face-to-face therapy, self-help with support based on CBT principles is a viable alternative 2
Treatment Algorithm
Initial Assessment:
First-Line Treatment:
Monitoring and Adjustment:
Maintenance:
Common Pitfalls to Avoid
- Underutilizing psychological interventions like CBT, which have strong evidence for effectiveness 1
- Premature discontinuation of medication before adequate trial period (minimum 4-6 weeks) 5
- Failure to continue medication for sufficient duration after symptom improvement (6-12 months recommended) 6
- Not addressing comorbid conditions that may complicate anxiety treatment 3
- Using benzodiazepines as first-line treatment for chronic anxiety management (they are not recommended for routine use due to dependence potential) 6
By following this evidence-based approach combining appropriate pharmacotherapy and psychological interventions, most patients with newly diagnosed anxiety can achieve significant symptom improvement and enhanced quality of life 2, 3.